香港股市 已收市

Minerva Surgical, Inc. (UTRS)

OTC Markets OTCPK - OTC Markets OTCPK 延遲價格。貨幣為 USD。
加入追蹤清單
0.00100.0000 (0.00%)
收市:01:18PM EDT

Minerva Surgical, Inc.

4255 Burton Drive
Santa Clara, CA 95054
United States
855 646 7874
https://minervasurgical.com

版塊Healthcare
行業Medical Devices
全職員工174

高階主管

名稱頭銜支付行使價出生年份
Mr. Todd UsenPresident, CEO & Director1967
Mr. Greg SimbroVice President of Finance
Mr. Erik ReeseVice President of Sales
Ms. Wendy BowmanVice President of Human Resources
Dr. Evgueni V. Skalnyi M.D.Chief Medical Officer365.25k1966
Ms. Joanne LongVice President of Corporate Controller
截止 2020年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

公司管治

截至 無 止,Minerva Surgical, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。